Abbott Finally Escapes Consent Decree
Source After more than a dozen years, Abbott Laboratories is no longer operating under a consent decree. The settlement was made in 1999 after a remarkable six-year run of manufacturing deficiencies and subsequent failures to fix various problems in its diagnostics division. The decree was terminated last month, according to an Abbott spokeswoman. The move […]
Read More »Category : News
FDA Panel Okays Arena Diet Pill
Source In a move that may herald a new era in fighting fat, an FDA advisory panel this afternoon voted 18-to-4 to recommend the agency approve the Arena Pharmaceutical diet pill, which is known as Lorqess. This marks the second time in three months that an FDA panel has decided the benefits of reducing the […]
Read More »Category : News
Buh-Bye Pfizer Pensions
Source First, Pfizer recently told employees that severance packages would be reduced as of mid-May. Now, the big drugmaker plans to eliminate its defined benefit pension plan as of 2018 and will direct employees to funnel their money into a 401K investment account, according to a company memo. And the pending changes will apply to […]
Read More »Category : News
Researchers Fight Over Chantix and Heart Risks
A spat has broken out among researchers over the extent to which the controversial Chantix quit-smoking pill is linked to cardiovascular risks. A meta-analysis that was published last week in BMJ found the drug, which is sold by Pfizer, does not increase the risk of heart attacks and strokes. The results contrast with a meta-analysis […]
Read More »Category : News
Lilly and Abbott Come Out On Top In Rep Overtime Case
Source In a decision that bolsters the pharmaceutical industry, a federal appeals court has ruled that sales reps are not eligible for overtime pay. In doing so, the court also rejected the position taken by the US Department of Labor, which has filed briefs in numerous cases supporting the notion that sales reps are entitled […]
Read More »Category : News
Swiss pharmaceutical company issues recall of Nebraska lethal injection drug
A Swiss pharmaceutical company has issued a voluntary recall of a lethal injection drug held by Nebraska, but state officials said Wednesday they won’t return the drug and the U.S. Food and Drug Administration says it won’t enforce the company’s decision. Naari AG asked Nebraska officials to quarantine its supply of sodium thiopental and return […]
Read More »Category : News
USDA asks MPI to reconfigure enclosures after animal death
MPI Research must reconfigure its enclosures after they led to the death of a non-human primate, a USDA report obtained by animal rights activists shows.
Read More »Category : News
Patheon Axes UK Jobs
Patheon has announced plans to reduce the scale and scope of business at its Swindon, UK facility. The move is part of the company’s ongoing corporate transformation strategy, which is intended to “enhance capacity utilization, focus capital investments on its core business, and accelerate operational excellence programs to increase efficiency, meet customer needs, and improve […]
Read More »Category : News
Indian Drug Regulatory and Pharma Embroiled in Scandal Over Approvals
Source A scandal is unfolding in India where a report by a parliamentary committee has found that the Drug Controller General has approved, on average, one new drug each month between 2008 and 2010 without conducting mandatory clinical trials or seeking expert medical opinions. As a result, the committee asked the health ministry to withdraw […]
Read More »Category : News
Pharma Gripes About the Details of Cetero Bankruptcy
Source It was bound to happen. As Cetero Research navigates bankruptcy proceedings, some drugmakers are bristling over the value of past work that the contract research organization conducted or how previous contracts will be honored. For instance, Kythera Biopharmaceuticals wants to be repaid at least $245,600 over complaints that Cetero botched development work (read this). […]
Read More »Category : News
